 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
3 g2 g. I% H+ Y0 `+ p: e) x % [5 B4 g, B" }
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.9 w" B2 F1 R5 j3 u% v: n: r
4 p1 c% d3 y: iBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
: ]4 z% b9 y6 J* F, s- V0 ~2 d ' m( V8 A8 a8 O8 m& [
b7 d, e T F h* h2 }# _EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
. |6 }3 y+ \% C5 `
0 c! |; E; b6 p+ F% o" |; V: Y- lThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
B2 R& ~& j% |: [8 k+ n" T R+ H
+ m: G6 `7 f* {) \. FThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.9 r7 O3 ^. F. a' V
" D Z# j M5 k5 AIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
) w Z: h+ K; T( U5 x% Q. J0 N q. [( ^
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
# n% h" d, y( n+ I. n" e `" y* d) X8 r* t0 i4 a" q( M# m' C8 ]
"As a scientist, it's one of the highlights of my CAREER," Shan said.
6 h( m3 [, ?/ v3 _1 ]5 n# T d
- u, Q \6 Q4 H& ~( p3 h6 {"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
9 s$ v" Y) z$ Q2 O, Q8 q" X" a/ G l; p/ |! S3 T
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.! p* p0 K( s7 C
0 [! l* u) ~5 `+ ?" \! G6 k" {) l- k
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.% R" p. O0 I1 U. c' S
* t x. k7 e5 O) U9 X! g, m8 qThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.7 ~, v d$ E* z
- k) H7 A" t0 }# @: @9 P
* H7 Q: J1 `/ P. O5 ?+ ]0 q5 ~http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
0 a9 ^7 y3 V* r1 [
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
# `! x. g' Z1 @
发表于 2015-2-28 19:45
